The latest price target for Jasper Therapeutics (NASDAQ:JSPR) was reported by RBC Capital on November 11, 2025. The analyst firm set a price target for $4.00 expecting JSPR to rise to within 12 months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback